PHARMACOECONOMIC EVALUATION FOR REIMBURSEMENT PURPOSES IN BULGARIA- RECENT UPDATES
Author(s)
Stoimenova A1, Savova A1, Benisheva-Dimitrova T2, Kamusheva M1, Petrova G3
1Medical University, Faculty of Pharmacy, Sofia, Bulgaria, 2NATIONAL COUNCIL ON PRICES AND REIMBURSEMENT OF MEDICINAL PRODUCTS, Sofia, Bulgaria, 3Medical University Sofia, Faculty of Pharmacy, Sofia, Bulgaria
OBJECTIVES: Our study evaluates the preferred methods which the pharmacoeconomic evaluations submitted for reimbursement purposes in Bulgaria are using. METHODS: This is retrospective, descriptive study. We have examined all applications submitted to National Council on Pricing and Reimbursement in 2013 on which positive opinion was issued. Quantitatively and qualitatively descriptive analyses towards the new molecules were carried out based on the submitted pharmacoeconomic evaluations. RESULTS:
Conference/Value in Health Info
2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands
Value in Health, Vol. 17, No. 7 (November 2014)
Code
PHP261
Topic
Health Policy & Regulatory
Topic Subcategory
Approval & Labeling
Disease
Multiple Diseases